{"id":"W4415619203","doi":"10.51731/cjht.2025.1266","title":"Durvalumab (Imfinzi) and Tremelimumab (Imjudo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Tremelimumab; Vinorelbine; Epidermal growth factor receptor; Drug; Clinical Oncology; Reimbursement; Lymphoma; Discontinuation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002195327,0.0003196138,0.0007516522,0.001955202,0.0002660953,0.001210553,0.0004440402,0.0004694021,0.004839043],"category_scores_gemma":[0.005567366,0.0001284389,0.0009961221,0.002378851,0.0002353502,0.0005933651,0.0002869203,0.0005958691,0.0006658771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003775869,"about_ca_system_score_gemma":0.006487437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03393611,"about_ca_topic_score_gemma":0.1343583,"domain_scores_codex":[0.998246,0.0004233297,0.000176798,0.0000820524,0.0009727669,0.00009911794],"domain_scores_gemma":[0.9970072,0.00104295,0.0007149383,0.00005197692,0.001051588,0.0001313519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000574511,0.0000391845,0.001337474,0.01481523,0.0007516102,0.00009318152,0.000053167,0.0002883843,0.001204953,0.003557651,0.03720761,0.9400771],"study_design_scores_gemma":[0.0003214357,0.0004495983,0.0106908,0.01297199,0.001679519,0.0006606221,0.00008885028,0.0002185463,0.001272174,0.0009807115,0.9706357,0.00003002687],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.005020942,0.9617368,0.0006861947,0.003136715,0.0003580062,0.0001743391,0.001911125,0.00005185024,0.02692389],"genre_scores_gemma":[0.07030565,0.9091862,0.004548495,0.002428887,0.0003566178,0.0002346847,0.002354362,0.00002676719,0.01055847],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03393611,"threshold_uncertainty_score":0.06747717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02002190801638784,"score_gpt":0.2969294342109829,"score_spread":0.276907526194595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}